-
Check-Cap Announces C-Scan System Version 3 Interim Results
americanpharmaceuticalreview
September 05, 2018
The objective of the study is to assess safety and clinical performance of the C-Scan system Version 3 in detecting patients with polyps. In a recent multi-center study on 31 evaluable patients, the C-Scan system Version 3, equipped with improved algorith
-
SQI Diagnostics to Announce Second Quarter 2018 Results
biospace
April 28, 2018
SQI Diagnostics In today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2018 at 5:00 p.m.
-
Abbott Reports First-Quarter 2018 Results
biospace
April 19, 2018
Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2018.
-
ResMed to Announce Third Quarter Fiscal Year 2018 Results
biospace
March 30, 2018
ResMed (NYSE: RMD) today announced it will report its third quarter of fiscal year 2018 results on Thursday, April 26, 2018, after the New York Stock Exchange market closes
-
DarioHealth Reports Fourth Quarter and Year End 2017 Results
biospace
March 20, 2018
DarioHealth Corp. (NASDAQ: DRIO),today reported financial and operational results for the fourth quarter and full-year periods ended on December 31, 2017.
-
Roche reports good results in 2017
worldpharmanews
February 06, 2018
In 2017, Roche Group sales rose 5% to CHF 53.3 billion.
-
Lanxess posts third quarter results
expressbpd
December 07, 2017
Speciality chemicals company LANXESS has posted its third quarter results.
-
FDA Warns Americans About Risk of Inaccurate Results from Certain Lead Tests
drugs.com
May 18, 2017
The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in the United States.
-
QuintilesIMS Reports First-Quarter 2017 Results and Raises Full-Year 2017 Adjusted Diluted EPS Guida
quintilesims
May 04, 2017
Quintiles IMS Holdings, Inc. reported financial results for the quarter ended March 31, 2017.
-
Syngene posts FY17 results : Registers a revenue of Rs 1272 crores
financialexpress
May 02, 2017
Syngene has recently posted its FY17 results. The company has posted a revenue of Rs 1272 crores and the EBITDA was up by 24 per cent to Rs 478 crores.